Castle Biosciences Patents – Key Insights and Stats

Castle Biosciences has a total of 87 patents globally, out of which 34 have been granted. Of these 87 patents, more than 58% patents are active. The USA is where Castle Biosciences has filed the maximum number of patents, followed by European Countries and Canada, it has generated an annual revenue of $94 million in the year 2021. Parallelly, China seems to be the main focused R&D centre of Castle Biosciences.

Castle Biosciences was founded in the year 2007 by Derek J. Maetzold. Company is a biotech company that develops and validates diagnostic tests and technologies for the treatment of cancer. As of August 2022, Castle Biosciences has a market cap of $814.84 million.

Do read about some of the most popular patents of Castle Biosciences which have been covered by us in this article and also you can find Castle Biosciences patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Castle Biosciences patent portfolio.

How many patents does the founder and the CEO of Castle Biosciences have?

The founder and CEO, Derek J. Maetzold, has 10 patents.

How many patents does Castle Biosciences have?

Castle Biosciences has a total of 87 patents globally. These patents belong to 20 unique patent families. Out of 87 patents, 51 patents are active.

How Many Patents did Castle Biosciences File Every Year?

Castle Biosciences Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantCastle Biosciences Applications FiledCastle Biosciences Patents Granted
20111
2012122
201323
201413
201521
2016112
20173
201814
201964
202055
202162
202214

How many Castle Biosciences patents are Alive/Dead?

Castle Biosciences Patent Portfolio

How Many Patents did Castle Biosciences File in Different Countries?

Castle Biosciences Worldwide Patent Filing

Countries in which Castle Biosciences Filed Patents

CountryPatents
United States Of America26
Europe11
Canada9
Australia7
Germany5
Israel4
Spain3
Japan3
Brazil2
India2
New Zealand1
Singapore1

Where are Research Centres of Castle Biosciences Patents Located?

R&D Centres of Castle Biosciences

10 Best Castle Biosciences Patents

US6618679B2 is the most popular patent in the Castle Biosciences portfolio. It has received 285 citations so far from companies like Illumina, Integenx, and Gen-Probe.

Below is the list of 10 most cited patents of Castle Biosciences:

Publication NumberCitation Count
US6618679B2285
US20080124726A1156
US20030204322A165
US7824856B243
US20060281108A122
US7897750B219
US8114615B28
US8597899B27
EP2636755A16
WO2012178058A16

EXCLUSIVE INSIGHTS COMING SOON!

What are Castle Biosciences’ key innovation segments?

What Technologies are Covered by Castle Biosciences’?

This image has an empty alt attribute; its file name is Tech-Area-Blur-22-1024x576.webp

The chart below distributes patents filed by Castle Biosciences’ in different countries on the basis of the technology protected in patents. It also represents the markets where Castle Biosciences’ thinks it’s important to protect particular technology inventions.

This image has an empty alt attribute; its file name is Tech-Protected-blur-22-1024x576.jpg

R&D Focus: How Castle Biosciences’ search focus changed over the years?

This image has an empty alt attribute; its file name is Technology-Through-the-year-Blur-22-1024x576.jpg

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Castle Biosciences’?

Table of Content

Insights you may find interesting

Related Articles

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.